Abstract
Objective The aim of our study was to detect the localization of gray matter atrophy in FOG PD patients compared with nFOG PD patients.
Methods A total of 155 PD patients (110 men and 45 women) were included in the current study. Forty-five patients were classified as FOG and one hundred and ten patients were classified as nFOG. A voxel-based morphometry approach was used to investigate the atrophy area of voxel clusters in the gray matter which is associated with FOG.
Results FOG and nFOG PD patients were not significantly different in gender, average age, educational years, disease duration or UPDRS-part I. Compared with nFOG PD patients, FOG patients showed gray matter atrophy in right Inferior frontal gyrus (opercular part), left Superior frontal gyrus, left Superior temporal gyrus, left Amygdala, left Insula, left Medial superior frontal gyrus and left Medial frontal gyrus (orbital gyrus).
Conclusion Our study identified new gray matter atrophy areas in FOG PD patients compared with nFOG patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by Ruijin Hospital Guangci Excellence Youth Training Program (KH, GCQN-2019-B10); Shanghai Pujiang Program (KH, 19PJ1407500), Shanghai Municipal Health Commission Clinical Study Special Fund (KH, 20194Y0067).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
PPMI database (www.ppmi-info.org/data) was our primary source of data in this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of Interest: There is no interest to disclosure.
Funding: This study was supported by Ruijin Hospital Guangci Excellence Youth Training Program (KH, GCQN-2019-B10); Shanghai Pujiang Program (KH, 19PJ1407500), Shanghai Municipal Health Commission Clinical Study Special Fund (KH, 20194Y0067).
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam.